16 results
·
19ms
·
Sources: EU EUDAMED, US FDA
CONCENTRIC RETRIEVER, MODEL 90030
FDA 510(k)
FDA Class 2
·Cardiovascular
Kirschner wire
FDA UDI
ADLER ORTHO SPA·08054752863408·TIPLESS KIRSHNER WIRE D2mm L=150mm
Custom Procedure Kit
FDA UDI
MEDIVATORS INC.·40677964023222·Endo Carry-on Procedure Kit includes Olympus 5-...
Navagio
FDA UDI
Kalitec Direct LLC·B07330K0134100·Trial, TLIF, 27L OB STR 7Deg, 10mm
AUTOSOFT XC
FDA Adverse Event
Malfunction
·UNOMEDICAL DEVICES S.A. DE C.V.·Product code FPA·May 22, 2025
TANDEM T:SLIM INSULIN DELIVERY SYSTEM
FDA Adverse Event
Malfunction
·TANDEM DIABETES CARE INC.·Product code LZG·November 6, 2014
PHORESOR MODEL PM2000
FDA 510(k)
FDA Class 2
·Physical Medicine
SYNCHRON SYSTEMS ALCOHOL REAGENT AND CALIBRATORS
FDA 510(k)
FDA Class 2
·Clinical Toxicology
STEM EXTRACTOR F/GUIDE BAR
FDA Adverse Event
Malfunction
·SYNTHES GMBH·Product code HWB·February 28, 2013
OT PING METER
FDA Adverse Event
Malfunction
·LIFESCAN INC.·Product code NBW·March 1, 2011
ROTALINK PLUS
FDA Adverse Event
Malfunction
·BOSTON SCIENTIFIC·Product code MCX·February 21, 2008
EVOLUT FX DCS
FDA Adverse Event
Malfunction
·MEDTRONIC HEART VALVES DIVISION·Product code NPT·June 25, 2025
Gambro Cartridge Blood Set, 003410-510, is intended for single use in a hemodialysis treatment using the Phoenix and Centry system 3 Dialysis Delivery Systems.
FDA Recall
Terminated
·Gambro Renal Products, Inc.·Product code FJK·May 2, 2008
smiths medical portex Venn Reusable Tracheal Tube Introducer, 15Ch x 60cm, REF 14-504-17 and REF 14-504-17JP
FDA Enforcement
Class II
·Ongoing·Smiths Medical ASD, Inc.·December 4, 2024
Ultrasound System 1300, bkSpecto w/battery; Model No. 1300-21 or 1300-S1; System, Imaging, Pulsed Doppler, Ultrasonic
FDA Enforcement
Class II
·Ongoing·B-K Medical A/S·November 12, 2025
CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.
FDA Enforcement
Class I
·Ongoing·Smiths Medical ASD Inc.·August 14, 2024